» Articles » PMID: 36561957

Health Effects and Known Pathology Associated with the Use of E-cigarettes

Abstract

In recent years, new nicotine delivery methods have emerged, and many users are choosing electronic cigarettes (e-cigarettes) over traditional tobacco cigarettes. E-cigarette use is very popular among adolescents, with more than 3.5 million currently using these products in the US. Despite the increased prevalence of e-cigarette use, there is limited knowledge regarding the health impact of e-cigarettes on the general population. Based on published findings by others, E-cigarette is associated with lung injury outbreak, which increased health and safety concerns related to consuming this product. Different components of e-cigarettes, including food-safe liquid solvents and flavorings, can cause health issues related to pneumonia, pulmonary injury, and bronchiolitis. In addition, e-cigarettes contain alarmingly high levels of carcinogens and toxicants that may have long-lasting effects on other organ systems, including the development of neurological manifestations, lung cancer, cardiovascular disorders, and tooth decay. Despite the well- documented potential for harm, e-cigarettes do not appear to increase susceptibility to SARS-CoV- 2 infection. Furthermore, some studies have found that e-cigarette users experience improvements in lung health and minimal adverse effects. Therefore, more studies are needed to provide a definitive conclusion on the long-term safety of e-cigarettes. The purpose of this review is to inform the readers about the possible health-risks associated with the use of e-cigarettes, especially among the group of young and young-adults, from a molecular biology point of view.

Citing Articles

Lush Ice High: A Rare Case of Nicotine E-Liquid-Induced Toxic Encephalopathy.

George S, Braha M, Chaudhary S, Aziz M Cureus. 2025; 17(1):e77486.

PMID: 39958056 PMC: 11828710. DOI: 10.7759/cureus.77486.


Immunological Effects of Electronic Cigarette Use: A Review of Current Evidence.

Zima K, Bogucka A, Wojtas M, Zabielska-Kaczorowska M Clin Rev Allergy Immunol. 2025; 68(1):9.

PMID: 39891861 DOI: 10.1007/s12016-025-09026-5.


Seizure Susceptibility in E-cigarette Users: Navigating the Clinical Management and Public Health Considerations.

Toluwalashe S, Aremu O, Ekerin O, Lawal A, Oluwatobi F, Adebayo V Subst Use. 2024; 18:29768357241304298.

PMID: 39618920 PMC: 11607758. DOI: 10.1177/29768357241304298.


Vaping Possible Negative Effects on Lungs: State-of-the-Art From Lung Capacity Alteration to Cancer.

Rahim F, Toguzbaeva K, Sokolov D, Dzhusupov K, Zhumagaliuly A, Tekmanova A Cureus. 2024; 16(10):e72109.

PMID: 39574999 PMC: 11580103. DOI: 10.7759/cureus.72109.


Patterns, clusters, and transitions in U.S. state ENDS policy implementation: 2010-2020.

Zaborenko C, Vuolo M, Maggs J, Staff J, Kelly B PLOS Glob Public Health. 2024; 4(11):e0003636.

PMID: 39536032 PMC: 11560037. DOI: 10.1371/journal.pgph.0003636.


References
1.
Walele T, Bush J, Koch A, Savioz R, Martin C, OConnell G . Evaluation of the safety profile of an electronic vapour product used for two years by smokers in a real-life setting. Regul Toxicol Pharmacol. 2017; 92:226-238. DOI: 10.1016/j.yrtph.2017.12.010. View

2.
Cant A, Collard B, Cunliffe D . Electronic cigarettes: Necrotic ulcer. Br Dent J. 2017; 222(4):226. DOI: 10.1038/sj.bdj.2017.150. View

3.
McDonald E, Ling P . One of several 'toys' for smoking: young adult experiences with electronic cigarettes in New York City. Tob Control. 2015; 24(6):588-93. PMC: 4492884. DOI: 10.1136/tobaccocontrol-2014-051743. View

4.
Brown C, Cheng J . Electronic cigarettes: product characterisation and design considerations. Tob Control. 2014; 23 Suppl 2:ii4-10. PMC: 3995271. DOI: 10.1136/tobaccocontrol-2013-051476. View

5.
Madsen L, Krarup N, Bergmann T, Baerentzen S, Neghabat S, Duval L . A Cancer That Went Up in Smoke: Pulmonary Reaction to e-Cigarettes Imitating Metastatic Cancer. Chest. 2016; 149(3):e65-7. DOI: 10.1016/j.chest.2015.09.003. View